Abstract
Objectives: Different techniques have been introduced to perform laparoscopic nephrectomy using either the transperitoneal or the retroperitoneal route. However, to date only few data exist comparing the results and morbidity of these procedures as well as with the standard technique of open nephrectomy. Material and Methods: This paper compares the clinical results of 18 transperitoneal laparoscopic nephrectomies (TLN) for benign renal disease with 17 retroperitoneal laparoscopic nephrectomies (RLN) and 19 consecutive open nephrectomies (Nx). All groups were comparable in terms of indication. The analysis of clinical data included operative time, morbidity, length of analgesic use and postoperative hospital stay. Results: The mean operative time for benign disease was 206.5 for TLN, 211.2 for RLN and 117 min for open nephrectomy. Analgesic medication requirement per patient was 2 days for TLN, 1 day for RLN and 4 days for Nx while the postoperative hospital stay averaged 7 days for TLN, 6 days for RLN and 10 days for Nx. The time of convalescence was 21 days after RLN, 24 days after TLN versus 40 days after open nephrectomy. Conclusions: Our results demonstrate an overall clear advantage of a laparoscopic approach when compared to open surgery and also reveals distinct benefits of a retroperitoneal approach.
References
1.
Simon G: Chirurgie der Niere, 1. Teil. Erlangen, Emke, 1871.
2.
Mayor G, Zingg EJ: Urologische Operationen, Atlas zur Indikation Technik und Nachbehandlung. Stuttgart, Thieme, 1973, pp 106–134.
3.
Crawford ED: Nephrectomy and nephroureterectomy; in Gleen JF (ed): Urologic Surgery, ed 4. Philadelphia, Lipincott, Tokyo, New York, 1991, pp 22–41.
4.
Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Meretyk S, Darcy MD, Roemer FD, Pingleton ED, Thomson PG, Long SR: Laparoscopic nephrectomy: Initial case report. J Urol 1991;146:278–282.
5.
Rassweiler J, Henkel TO, Potempa DM, Coptcoat M, Alken P: The technique of transperitoneal laparoscopic nephrectomy, adrenalectomy, and nephroureterectomy. Eur Urol 1993;23:425–430.
6.
Gill IS, Kavoussi LR, Clayman RV, Ehrlich R, Evans R, Fuchs G, Gerham A, Hulbert JC, McDougall EM, Rosenthal T, Schuessler WW, Shepard T: Complications of laparoscopic nephrectomy in 185 patients: A multi-institutional review. J Urol 1995;154:479–483.
7.
Gaur D: Laparoscopic operative retroperitoneoscopy. J Urol 1992;148:1137–1139.
8.
Rassweiler J, Henkel TO, Stock C, Greschner M, Becker P, Preminger GM, Schulman CC, Frede T, Alken P: Retroperitoneal laparoscopic nephrectomy and other procedures in the upper retroperitoneum using a balloon dissection technique. Eur Urol 1994;25:229–236.
9.
Rassweiler JJ, Henkel TO, Stock C, Frede T, Alken P: Retroperitoneoscopic surgery: Technique, indications and first experience. Minim Invas Ther 1994;3:179–195.
10.
Clayman RV, Kavoussi LR, Long SR, Dierks SM, Meretyk S, Sopper NJ: Laparoscopic nephrectomy: Initial report of pelviscopic organ ablation in the pig. J Endourol 1990;4:247–251.
11.
Troidel H, Gaitzsch A, Wilfurth W, Müller W: Fehler und Gefahren bei der laparoskopischen Appendektomie (Engl. abstract). Chirurg 1993;64:212–215.
12.
Kerbl K, Clayman RV, McDougall EM, Urban DA, Gill I, Kavoussi LR: Laparoscopic nephroureterectomy: Evaluation of first clinical series. Eur Urol 1993;23:431–434.
13.
Henkel TO, Potempa DM, Rassweiler J, Frede T, Stock C, Alken P: Experimental studies for clinical standardization of transabdominal laparoscopic nephrectomy. Eur Urol 1994;25:55–61.
14.
Weinberg JJ, Smith AD: Percutaneous resection of the kidney: Preliminary report. J Endourol 1988;2:355–359.
15.
Kerbl K, Figenshau RS, Clayman RV, Chandhoke PS, Kavoussi LR, Albala DM, Stone AM: Retroperitoneal laparoscopic nephrectomy: Laboratory and clinical experience. J Endourol 1993;7:23–26.
16.
Gaur DD, Agarwal DK, Purohit KC: Retroperitoneal laparoscopic nephrectomy: Initial case report. J Urol 1993;149:1031–1032.
17.
Rassweiler JJ, Seemann O, Henkel T, Alken P: Retroperitoneoscopy: Experience with the first 200 patients (abstr 560). J Urol 1997;157:143A.
18.
Kavoussi LR, Sosa RE, Capelouto C: Complications of laparoscopic surgery. J Endourol 1992;6:95-98.
19.
Ruitz R, Novick AC, Braun WE, Montague DK, Stewart BH: Transperitoneal live donor nephrectomy. J Urol 1980;123:819–821.
20.
Marco T, Amin M, Harty JI: Living donor nephrectomy: Factors influencing morbidity. J Urol 1982;127:1082–1083.
21.
Blohme I, Fehrman I, Norden G: Living donor nephrectomy. Scand J Urol Nephrol 1992;26:149–151.
22.
Clayman RV, McDougall EM, Kerbl K, Anderson K, Kavoussi LR: Laparoscopic nephrectomy: Transperitoneal versus retroperitoneal (abstr 459). J Urol 1994;151:342A.
23.
Rassweiler JJ, Fornara P, Fahlenkamp D, Weber M, Beer M, Lampel A, Janetschek G, Stackl W: Laparoscopic nephrectomy: The Austrian-German Experience. (abstr 1582). J Urol 1997;157:403A.
24.
Bishop JK, Halpin TF: Dehiscense following laparoscopy: Report of an unusual complication. Am J Gynecol 1973;116:585–586.
25.
Thomas AG, McLymont F, Moshipur J: Incarcerated hernia after laparoscopic sterilization: A case report. J Reprod Med 1990;35:639–640.
26.
Winfield HN, Hamilton BD, Bravo EL, Novick AC: Comparison of laparoscopic and open adrenalectomy (abstr P6-31). J Endourol 1997;11:S131.
27.
Kavoussi L: Laparoscopic donor nephrectomy. J Endourol 1997;11:S45.
28.
Jacobs SC, Cjho E, Bartlett ST, Flowers JL: A one year experience with laparoscopic living donor nephrectomy (abstr P6-21). J Endourol 1997;11:S128.
29.
Clayman RV: Laparoscopy – use it or loose it! (BAUS-lecture). J Endourol 1997;11:S45.
30.
Coptcoat MJ: Laparoscopy in urology: Perspective and practice. Br J Urol 1992;69:561–567.
31.
Coptcoat MJ, Rassweiler JJ: Die Zukunft der laparoskopischen Chirurgie in der Urologie (Engl. abstract). Urologe [A] 1996;35:226–232.
32.
Janetschek G, Rassweiler J: Future outlook; in Janetschek G, Rassweiler J, Griffiths D (eds): Laparoscopic Surgery in Urology. Stuttgart, Thieme, 1997, pp 276–280.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
